Aberrant HJURP expression is common in tumors, including hepatocellular carcinoma (Chen T. et al., 2019), renal cell carcinoma (Zhang et al., 2021), ovarian cancer (Dou et al., 2022), osteosarcoma (Jia et al., 2022), pancreatic cancer (Wang C. J. et al., 2020), and oral cancer (Tsevegjav et al., 2022). Here, HJURP is linked to lip and oral cavity carcinoma.